Rigel Pharmaceuticals | RIGL - Interest Income


Rigel Pharmaceuticals reported $0.7 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Arrowhead Research USD 9.69M 637K Dec/2025
AstraZeneca USD 73M 62M Mar/2026
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Daiichi Sankyo JPY 9.96B 230M Mar/2024
Eli Lilly USD 65M 25M Sep/2025
Heron Therapeutics USD 433K 277K Dec/2021
Intrexon USD 319K 602K Jun/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 6.39M 2.52M Dec/2025
MacroGenics USD 1.53M 114K Sep/2025
Pfizer USD 115M 51M Mar/2026
Regeneron Pharmaceuticals USD 193.3M 18.2M Dec/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
Veracyte USD 3.48M 545K Sep/2025